BRAIN Biotech AG
XETRA:BNN

Watchlist Manager
BRAIN Biotech AG Logo
BRAIN Biotech AG
XETRA:BNN
Watchlist
Price: 3.44 EUR -0.86%
Market Cap: 75.2m EUR
Have any thoughts about
BRAIN Biotech AG?
Write Note

BRAIN Biotech AG
Accounts Payable

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

BRAIN Biotech AG
Accounts Payable Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Accounts Payable CAGR 3Y CAGR 5Y CAGR 10Y
BRAIN Biotech AG
XETRA:BNN
Accounts Payable
€4.5m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Wacker Chemie AG
XETRA:WCH
Accounts Payable
€858.2m
CAGR 3-Years
13%
CAGR 5-Years
20%
CAGR 10-Years
10%
Evonik Industries AG
XETRA:EVK
Accounts Payable
€1.5B
CAGR 3-Years
-2%
CAGR 5-Years
3%
CAGR 10-Years
4%
Covestro AG
XETRA:1COV
Accounts Payable
€2B
CAGR 3-Years
3%
CAGR 5-Years
8%
CAGR 10-Years
N/A
AlzChem Group AG
XETRA:ACT
Accounts Payable
€31.6m
CAGR 3-Years
15%
CAGR 5-Years
0%
CAGR 10-Years
N/A
Symrise AG
XETRA:SY1
Accounts Payable
€438.6m
CAGR 3-Years
8%
CAGR 5-Years
8%
CAGR 10-Years
N/A
No Stocks Found

BRAIN Biotech AG
Glance View

Market Cap
75.2m EUR
Industry
Chemicals

BRAIN Biotech AG is a technology company, which engages in the development and commercialization of bioactives, natural compounds, and proprietary enzymes. The company is headquartered in Zwingenberg, Hessen and currently employs 293 full-time employees. The company went IPO on 2016-02-09. Research & Development activities focus on bioactive natural compounds, tailored enzymes and high-performance microorganisms.

BNN Intrinsic Value
5.16 EUR
Undervaluation 33%
Intrinsic Value
Price

See Also

What is BRAIN Biotech AG's Accounts Payable?
Accounts Payable
4.5m EUR

Based on the financial report for Jun 30, 2024, BRAIN Biotech AG's Accounts Payable amounts to 4.5m EUR.

Back to Top